IDEAYA Biosciences Secures $46,000,000 Series A Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e63176ae-9b34-48c0-9314-db22b421c8c8 - Date
5/5/2016 - Company Name
IDEAYA Biosciences - Mailing Address
329 Oyster Point Boulevard 3rd Floor South San Francisco, CA 94080 USA - Company Description
At the core of a successful big biology and small molecule based drug discovery company is well understood pathobiology of the drug targets and excellent chemical matter to modulate them – one without the other ultimately equals failure. - Website
http://www.ideayabio.com - Transaction Type
Venture Equity - Transaction Amount
$46,000,000 - Transaction Round
Series A - Proceeds Purposes
The company is now capitalized to advance its research programs in synthetic lethality and immuno-oncology to clinical candidate selection and the clinic. IDEAYA was incubated by 5AM Ventures with a seed investment prior to its Series A financing. - M&A Terms
- Venture Investor
5AM Ventures - Venture Investor
Canaan Partners - Venture Investor
Celgene - Venture Investor
WuXi PharmaTech - Venture Investor
Novartis BioVenture Fund - Venture Investor
Alexandria Venture Investments
